tetradecanoylphorbol acetate has been researched along with quinidine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Greer, MA; Greer, SE; McAdams, S; Sato, N; Wang, XB | 1 |
| Cook, DI; Wegman, EA; Young, JA | 1 |
| Guo, X; Hopfer, U; Laboisse, CL; Merlin, D | 1 |
| Moran, A; Turner, RJ | 1 |
| Berkovic, SF; Dibbens, LM; Dlugos, DJ; Gazina, EV; Goldstein, DB; Heron, SE; Li, M; Milligan, CJ; Nair, U; Petrou, S; Petrovski, S; Reid, CA; Scheffer, IE; Trager, C; Venkat, A; Younkin, DP | 1 |
6 other study(ies) available for tetradecanoylphorbol acetate and quinidine
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Quinidine inhibits prolactin secretion induced by thyrotropin-releasing hormone, high medium potassium or hyposmolarity in GH4C1 cells.
Topics: Anti-Arrhythmia Agents; Humans; Osmolar Concentration; Pituitary Neoplasms; Potassium; Prolactin; Quinidine; Tetradecanoylphorbol Acetate; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors; Tumor Cells, Cultured | 1991 |
A 23-pS Ca2(+)-activated K+ channel in MCF-7 human breast carcinoma cells: an apparent correlation of channel incidence with the rate of cell proliferation.
Topics: Apamin; Breast Neoplasms; Calcium; Cell Division; Electric Conductivity; Epithelium; Humans; Potassium; Potassium Channels; Quinidine; Rubidium; Tamoxifen; Tetradecanoylphorbol Acetate; Tetraethylammonium Compounds; Tumor Cells, Cultured | 1991 |
Ca2+ and cAMP activate different K+ conductances in the human intestinal goblet cell line HT29-Cl.16E.
Topics: Amphotericin B; Barium; Bumetanide; Calcimycin; Calcium; Carbachol; Cell Line; Cell Membrane Permeability; Colforsin; Cyclic AMP; Digitonin; Diphenylamine; Electric Conductivity; Epithelial Cells; Epithelium; Fura-2; Humans; Intestinal Mucosa; Membrane Potentials; Models, Biological; Ouabain; Potassium; Potassium Channels; Quinidine; Tetradecanoylphorbol Acetate; Thionucleotides; Vasoactive Intestinal Peptide | 1995 |
Secretagogue-induced RVD in HSY cells is due to K+ channels activated by Ca2+ and protein kinase C.
Topics: Atropine; Barium; Calcium; Carbachol; Cell Line; Chloride Channels; Egtazic Acid; Humans; Ionomycin; Kinetics; Pirenzepine; Potassium; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Quinidine; Salivary Glands; Scorpion Venoms; Tetradecanoylphorbol Acetate; Valinomycin | 1993 |
KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Electric Stimulation; Humans; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Microinjections; Mutation; Nerve Tissue Proteins; Oocytes; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine; Tetradecanoylphorbol Acetate; Time Factors; Voltage-Gated Sodium Channel Blockers; Xenopus laevis | 2014 |